Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons
about
Edaravone guards dopamine neurons in a rotenone model for Parkinson's diseaseA staged screening of registered drugs highlights remyelinating drug candidates for clinical trialsA radical scavenger edaravone inhibits matrix metalloproteinase-9 upregulation and blood-brain barrier breakdown in a mouse model of prolonged cerebral hypoperfusionSpinal cord stimulation exerts neuroprotective effects against experimental Parkinson's disease.Protective effect of hydrogen sulphide against 6-OHDA-induced cell injury in SH-SY5Y cells involves PKC/PI3K/Akt pathwayAutophagy as an essential cellular antioxidant pathway in neurodegenerative disease.Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of central nervous system diseases.Oxidative stress interferes with white matter renewal after prolonged cerebral hypoperfusion in mice.Inhibitory effects of edaravone in β-amyloid-induced neurotoxicity in rats.Small molecule inhibitors in the treatment of cerebral ischemia.NADPH oxidases in oxidant production by microglia: activating receptors, pharmacology and association with disease.Edaravone prevents neurotoxicity of mutant L166P DJ-1 in Parkinson's disease.A free radical scavenger edaravone suppresses systemic inflammatory responses in a rat transient focal ischemia model.Molecular Mechanisms behind Free Radical Scavengers Function against Oxidative Stress.Neuroprotective effect of edaravone in experimental glaucoma model in rats: a immunofluorescence and biochemical analysis.Edaravone, a free radical scavenger, protects components of the neurovascular unit against oxidative stress in vitro.Edaravone protects human peripheral blood lymphocytes from γ-irradiation-induced apoptosis and DNA damage.Urinary 8-OHdG elevations in a partial lesion rat model of Parkinson's disease correlate with behavioral symptoms and nigrostriatal dopaminergic depletion.Edaravone ameliorates oxidative stress associated cholinergic dysfunction and limits apoptotic response following focal cerebral ischemia in rat.Potential of edaravone for neuroprotection in neurologic diseases that do not involve cerebral infarction.Protective Effects of Fisetin Against 6-OHDA-Induced Apoptosis by Activation of PI3K-Akt Signaling in Human Neuroblastoma SH-SY5Y Cells.Sodium Phenylbutyrate and Edaravone Abrogate Chronic Restraint Stress-Induced Behavioral Deficits: Implication of Oxido-Nitrosative, Endoplasmic Reticulum Stress Cascade, and Neuroinflammation.Antioxidant treatment ameliorates diabetes-induced dysfunction of the vas deferens in a rat model.Ameliorating effects of combined curcumin and desferrioxamine on 6-OHDA-induced rat mode of Parkinson's disease.Edaravone protects neurons in the rat substantia nigra against 6-hydroxydopamine-induced oxidative stress damage.Protective effects of a radical scavenger edaravone on oligodendrocyte precursor cells against oxidative stress.Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of aberrant cell cycle diseases: an update.SC79 protects dopaminergic neurons from oxidative stress.
P2860
Q27335848-FDAA8F84-36AA-4DDF-80E2-8786757459BDQ30844551-91795553-BF76-4C6A-8D7A-8E8D09109CA8Q33748058-5564B86C-F99E-4571-BA4C-2E0AFF044906Q33882321-2AE52767-1A75-4044-82A7-085260E08B24Q34339802-0D121BB4-358C-4C80-B0B2-EC79AEFF4D00Q37539279-368DEDBE-4BD2-478D-8C4A-2862B8F03580Q37640235-E763E8A6-573D-41FE-80CD-D684E9C71B1CQ37701407-01309059-F39B-4674-8D3C-9AF56D812452Q37718902-BDA8C850-505A-4DA4-AB7C-87534D49F861Q38184644-81B66438-47D1-44F6-9EED-D5F46834CE62Q38691764-9C2144C6-7A3A-4CF5-AA69-963F51AC0D2BQ39154570-EC0DE1D0-7CD7-42B4-8264-A2DF23F74DB1Q39427640-53EEEA6F-AEBF-49DB-B985-693AFB91EC6CQ39429504-972ADFBD-DA1C-4BA2-8E43-C7B5B7B75221Q40050004-64C2BCF7-968B-40BA-9C07-630176D011E8Q41837296-21A46A77-6FE4-47EC-9F28-ED9AB2C78C6EQ41913123-744A501A-2508-41E4-A773-3CE632E14422Q42478312-FAD9F2AC-38ED-4E89-B948-5656D021B707Q42507233-A6F41346-BEEA-4ED7-B95D-D87B21E21F06Q43079903-522CB9BA-7325-4875-928F-69B32D691354Q46248167-9A299376-D285-4992-9155-4CB0063ABAB9Q48063832-58E5A230-78EF-4F63-86EC-D3A49D516835Q48209312-2405A9CB-138B-4B6C-B546-59108C2907BFQ48681453-E48FCFD4-3422-4DE5-9264-E78ED029C814Q48706360-80123BDF-96CC-424A-9A8F-E7D32C66D27FQ50034037-7FE1F866-B186-49A6-A606-A2198F8C6B9DQ51604439-1EFBC541-5450-4142-AE76-C589E8BF4F64Q51737455-6BB49ED7-F2B7-40DA-A377-822E5E3C29C4
P2860
Neuroprotective effects of edaravone-administration on 6-OHDA-treated dopaminergic neurons
description
2008 nî lūn-bûn
@nan
2008 թուականին հրատարակուած գիտական յօդուած
@hyw
2008 թվականին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Neuroprotective effects of eda ...... A-treated dopaminergic neurons
@ast
Neuroprotective effects of eda ...... A-treated dopaminergic neurons
@en
Neuroprotective effects of eda ...... A-treated dopaminergic neurons
@en-gb
Neuroprotective effects of eda ...... A-treated dopaminergic neurons
@nl
type
label
Neuroprotective effects of eda ...... A-treated dopaminergic neurons
@ast
Neuroprotective effects of eda ...... A-treated dopaminergic neurons
@en
Neuroprotective effects of eda ...... A-treated dopaminergic neurons
@en-gb
Neuroprotective effects of eda ...... A-treated dopaminergic neurons
@nl
prefLabel
Neuroprotective effects of eda ...... A-treated dopaminergic neurons
@ast
Neuroprotective effects of eda ...... A-treated dopaminergic neurons
@en
Neuroprotective effects of eda ...... A-treated dopaminergic neurons
@en-gb
Neuroprotective effects of eda ...... A-treated dopaminergic neurons
@nl
P2093
P2860
P356
P1433
P1476
Neuroprotective effects of eda ...... A-treated dopaminergic neurons
@en
P2093
Feifei Wang
Hanbai Leung
Kenichiro Muraoka
Masahiro Kameda
Naoki Tajiri
Takamasa Morimoto
Takao Yasuhara
Takashi Agari
P2860
P2888
P356
10.1186/1471-2202-9-75
P407
P577
2008-01-01T00:00:00Z
P5875
P6179
1045623052